Back to trial details

Intake questionnaire

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Applying to Rutgers Cancer Institute of New Jersey · New Brunswick, New Jersey

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to New Brunswick for study visits?